UBS upgraded Altria Group (NYSE: MO) to Neutral from Sell, saying stepped-up enforcement against illicit e-cigarette imports, ...

Investing.com -- Regeneron Pharmaceuticals (NASDAQ: REGN) stock rose 2.8% after the U.S. Food and Drug Administration granted accelerated approval for the company’s blood cancer therapy Lynozyfic.

Investing.com -- Truist analysts raised their price target on Amazon (NASDAQ: AMZN) shares to $250 from $226 in a note Wednesday, maintaining a Buy rating on the stock. The firm cited expectations for ...

Bernstein analysts remain bullish on Starbucks (NASDAQ: SBUX), stating the stock could double from its post-second quarter ...

Cava, with about 400 locations and roots in the 2018 acquisition of Zoës Kitchen, is the “clear leader” in the still-nascent Mediterranean fast casual segment, the brokerage said. Its nearest rivals ...

Investing.com -- Dianthus Therapeutics (NASDAQ: DNTH) stock rose 5.8% after receiving its 13th buy rating, with William Blair ...

Oscar, a digital-focused insurer operating exclusively on the Affordable Care Act exchanges, laid out plans in June to more than double margins and deliver $2.25+ per share profit by 2027. Barclays is ...

Investing.com -- Shares of Centene (NYSE: CNC) plunged more than 32% in premarket trading Wednesday after the company pulled ...

Investing.com -- Goldman Sachs began coverage of mid‑cap U.S. athleisure names with a cautious stance, arguing that stiffer ...

Investing.com -- Wolfe Research downgraded Stellantis (NYSE: STLA) to Underperform in a note Wednesday, citing structural challenges and macroeconomic headwinds that could weigh on earnings and free ...

Redburn expects Adobe’s free cash flow (FCF) growth to slow to the low single digits by 2030, and now values the stock at 12x ...

Investing.com -- Instil Bio Inc (NASDAQ: TIL) stock surged 10% after the clinical-stage biopharmaceutical company announced the clearance of an Investigational New Drug (IND) application for AXN-2510 ...